- CA$11.05m
- CA$29.19m
- CA$2.54m
Brief: Pharmacielo Ltd Intends To Amend Existing Warrant Terms, And Issue Shares For Debt
Brief: PharmaCielo Ltd Reports Quarterly Loss Per Share Of $0.03
Brief: PharmaCielo Announces Shipment Of Dried Cannabis Flower To Czech Republic
Brief: PharmaCielo Announces Receipt Of Production Quota Of THC Dominant Dried Cannabis Flower For Export
Brief: Pharmacielo Announces Receipt Of Icann G.A.P And GACP Certifications, Opening Commercial Access To Israeli Market
Brief: PharmacCielo Announces First Shipment To Mexican Joint Venture Partner
Brief: PharmaCielo Announces Sales Agreement With Brazilian Phyto-Therapeutic Customer, And Key Management And Board Appointments
Brief: Pharmacielo Announces Shipment Of CBD Full Spectrum Oil To Brazilian Pharmaceutical Customer
Brief: Pharmacielo Announces Financial Results For The First Quarter Ended March 31, 2022
Brief: Pharmacielo Partners With Soteria Holdings To License, Import And Wholesale Its Medical Cannabis Flower
Brief: PharmaCielo Reports Financial Results For Q4 And Fiscal Year Ended Dec 31, 2021
Brief: Pharmacielo Signs Sales Agreement With Greenstein To Supply Thc Final Products Commercialized Through Noweda
Brief: Pharmacielo Announces $15 Mln Non-Brokered Private Placement Of Debenture Units
Brief: Pharmacielo Announces Q3-2021 Financial Results
Brief: PharmaCielo Receives Confirmation of Colombian Phytotherapeutics GMP Certification
Brief: Pharmacielo Appoints Bob Degabrielle And Will Nicholas To Board
Brief: PharmaCielo Signs Sales Agreement And Makes Initial Commercial Sale To Pharmaceutical Player In Brazil
Brief: Pharmacielo Makes Initial Shipment To Canadian Life Sciences Company
Brief: Pharmacielo Appoints Ian D. Atacan As CFO